Mapping the Binding Interface in a Noncovalent Size Variant of a Monoclonal Antibody Using Native Mass Spectrometry, Hydrogen-Deuterium Exchange Mass Spectrometry, and Computational Analysis

• Published in: Journal of pharmaceutical sciences Vol. 106; no. 11; p. 3222
• Main Authors: Yan, Yuetian, Wei, Hui, Jusuf, Sutjano, Krystek, Jr, Stanley R, Chen, Jie, Chen, Guodong, Ludwig, Richard T, Tao, Li, Das, Tapan K
• Format: Journal Article
• Language: English
• Published: United States 01-11-2017
• Subjects: Animals; Antibodies, Monoclonal - chemistry; Binding Sites, Antibody; CHO Cells; Chromatography, Gel; Cricetulus; Deuterium - analysis; Deuterium Exchange Measurement - methods; Humans; Hydrogen - analysis; Immunoglobulin G - chemistry; Mass Spectrometry - methods; Models, Molecular; Recombinant Proteins - chemistry; Spectrometry, Mass, Electrospray Ionization - methods; Structural Homology, Protein; protein structure; interaction; mass spectrometry; biopharmaceuticals characterization; IgG antibody; molecular modeling
• ISSN: 1520-6017
• DOI: 10.1016/j.xphs.2017.06.009

Variants of monoclonal antibody containing an extra light chain have been reported in protein products. Due to potential impact on potency and immunogenicity, it is important to understand the formation mechanism of such variants so that appropriate control strategies can be implemented to assure product quality. In a model monoclonal antibody, we observed a size variant with an extra light chain noncovalently associated with the monomer (later named as "1.2mer"). The interaction between monomer and the extra light chain was characterized by native spray and hydrogen-deuterium exchange mass spectrometry techniques. The goal is to understand the nature of the noncovalent interaction, to map out the interaction interface and regions of potential conformational distortions. In addition, computational modeling was used to aid in binding site identification. The combined results identify the interaction interface to be located in the heavy chain region 38-57 and in the extra light chain region 30-50. To the best of our knowledge, this study is the first to characterize noncovalent interaction of a size variant comprising an antibody monomer and an extra light chain. Structural knowledge generated in this research work is invaluable for process development and construct design of antibody-based biopharmaceuticals.